#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Connectome-based prediction of cocaine abstinence Objective: To identify a brain-based predictor of cocaine abstinence using a recently developed machine learning approach, connectome-based predictive modeling (CPM).
1-1	0-16	Connectome-based	_
1-2	17-27	prediction	_
1-3	28-30	of	_
1-4	31-38	cocaine	_
1-5	39-49	abstinence	_
1-6	50-59	Objective	_
1-7	60-61	:	_
1-8	62-64	To	_
1-9	65-73	identify	_
1-10	74-75	a	_
1-11	76-87	brain-based	_
1-12	88-97	predictor	_
1-13	98-100	of	_
1-14	101-108	cocaine	_
1-15	109-119	abstinence	_
1-16	120-125	using	_
1-17	126-127	a	_
1-18	128-136	recently	_
1-19	137-146	developed	_
1-20	147-154	machine	_
1-21	155-163	learning	_
1-22	164-172	approach	_
1-23	173-174	,	_
1-24	175-191	connectome-based	_
1-25	192-202	predictive	_
1-26	203-211	modeling	_
1-27	212-213	(	_
1-28	214-217	CPM	_
1-29	218-219	)	_
1-30	220-221	.	_

Text=CPM is a predictive tool and a method of identifying networks that underlie specific behaviors (‘ neural fingerprints ’).
2-1	222-225	CPM	_
2-2	226-228	is	_
2-3	229-230	a	_
2-4	231-241	predictive	_
2-5	242-246	tool	_
2-6	247-250	and	_
2-7	251-252	a	_
2-8	253-259	method	_
2-9	260-262	of	_
2-10	263-274	identifying	_
2-11	275-283	networks	_
2-12	284-288	that	_
2-13	289-297	underlie	_
2-14	298-306	specific	_
2-15	307-316	behaviors	_
2-16	317-318	(	_
2-17	319-320	‘	_
2-18	321-327	neural	_
2-19	328-340	fingerprints	_
2-20	341-342	’	_
2-21	343-344	)	_
2-22	345-346	.	_

Text=Methods: Fifty-three individuals participated in neuroimaging protocols at the start of treatment for cocaine-use disorder, and again at the end of 12-week treatment.
3-1	347-354	Methods	_
3-2	355-356	:	_
3-3	357-368	Fifty-three	_
3-4	369-380	individuals	_
3-5	381-393	participated	_
3-6	394-396	in	_
3-7	397-409	neuroimaging	_
3-8	410-419	protocols	_
3-9	420-422	at	_
3-10	423-426	the	_
3-11	427-432	start	_
3-12	433-435	of	_
3-13	436-445	treatment	_
3-14	446-449	for	_
3-15	450-461	cocaine-use	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
3-16	462-470	disorder	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
3-17	471-472	,	_
3-18	473-476	and	_
3-19	477-482	again	_
3-20	483-485	at	_
3-21	486-489	the	_
3-22	490-493	end	_
3-23	494-496	of	_
3-24	497-504	12-week	_
3-25	505-514	treatment	_
3-26	515-516	.	_

Text=CPM with leave-one-out cross-validation was run to identify pre-treatment networks that predicted abstinence (percent cocaine-negative urines during treatment).
4-1	517-520	CPM	_
4-2	521-525	with	_
4-3	526-539	leave-one-out	_
4-4	540-556	cross-validation	_
4-5	557-560	was	_
4-6	561-564	run	_
4-7	565-567	to	_
4-8	568-576	identify	_
4-9	577-590	pre-treatment	_
4-10	591-599	networks	_
4-11	600-604	that	_
4-12	605-614	predicted	_
4-13	615-625	abstinence	_
4-14	626-627	(	_
4-15	628-635	percent	_
4-16	636-652	cocaine-negative	_
4-17	653-659	urines	_
4-18	660-666	during	_
4-19	667-676	treatment	_
4-20	677-678	)	_
4-21	679-680	.	_

Text=Networks were applied to post-treatment fMRI data to assess changes over time and ability to predict abstinence during follow-up.
5-1	681-689	Networks	_
5-2	690-694	were	_
5-3	695-702	applied	_
5-4	703-705	to	_
5-5	706-720	post-treatment	_
5-6	721-725	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-7	726-730	data	_
5-8	731-733	to	_
5-9	734-740	assess	_
5-10	741-748	changes	_
5-11	749-753	over	_
5-12	754-758	time	_
5-13	759-762	and	_
5-14	763-770	ability	_
5-15	771-773	to	_
5-16	774-781	predict	_
5-17	782-792	abstinence	_
5-18	793-799	during	_
5-19	800-809	follow-up	_
5-20	810-811	.	_

Text=The predictive ability of identified networks was then tested in separate, heterogeneous sample of individuals scanned prior to treatment for cocaine use disorder (n=45).
6-1	812-815	The	_
6-2	816-826	predictive	_
6-3	827-834	ability	_
6-4	835-837	of	_
6-5	838-848	identified	_
6-6	849-857	networks	_
6-7	858-861	was	_
6-8	862-866	then	_
6-9	867-873	tested	_
6-10	874-876	in	_
6-11	877-885	separate	_
6-12	886-887	,	_
6-13	888-901	heterogeneous	_
6-14	902-908	sample	_
6-15	909-911	of	_
6-16	912-923	individuals	_
6-17	924-931	scanned	_
6-18	932-937	prior	_
6-19	938-940	to	_
6-20	941-950	treatment	_
6-21	951-954	for	_
6-22	955-962	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
6-23	963-966	use	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
6-24	967-975	disorder	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
6-25	976-977	(	_
6-26	978-982	n=45	_
6-27	983-984	)	_
6-28	985-986	.	_

Text=Results: CPM predicted abstinence during treatment, as indicated by a high correspondence between predicted and actual abstinence values (r (df=52) =0.42, p=0.001).
7-1	987-994	Results	_
7-2	995-996	:	_
7-3	997-1000	CPM	_
7-4	1001-1010	predicted	_
7-5	1011-1021	abstinence	_
7-6	1022-1028	during	_
7-7	1029-1038	treatment	_
7-8	1039-1040	,	_
7-9	1041-1043	as	_
7-10	1044-1053	indicated	_
7-11	1054-1056	by	_
7-12	1057-1058	a	_
7-13	1059-1063	high	_
7-14	1064-1078	correspondence	_
7-15	1079-1086	between	_
7-16	1087-1096	predicted	_
7-17	1097-1100	and	_
7-18	1101-1107	actual	_
7-19	1108-1118	abstinence	_
7-20	1119-1125	values	_
7-21	1126-1127	(	_
7-22	1128-1129	r	_
7-23	1130-1131	(	_
7-24	1132-1137	df=52	_
7-25	1138-1139	)	_
7-26	1140-1145	=0.42	_
7-27	1146-1147	,	_
7-28	1148-1155	p=0.001	_
7-29	1156-1157	)	_
7-30	1158-1159	.	_

Text=Identified networks included connections within and between canonical networks implicated in cognitive/ executive control (frontoparietal, medial frontal) and in reward responsiveness (subcortical, salience, motor/sensory).
8-1	1160-1170	Identified	_
8-2	1171-1179	networks	_
8-3	1180-1188	included	_
8-4	1189-1200	connections	_
8-5	1201-1207	within	_
8-6	1208-1211	and	_
8-7	1212-1219	between	_
8-8	1220-1229	canonical	_
8-9	1230-1238	networks	_
8-10	1239-1249	implicated	_
8-11	1250-1252	in	_
8-12	1253-1263	cognitive/	_
8-13	1264-1273	executive	_
8-14	1274-1281	control	_
8-15	1282-1283	(	_
8-16	1284-1298	frontoparietal	_
8-17	1299-1300	,	_
8-18	1301-1307	medial	_
8-19	1308-1315	frontal	_
8-20	1316-1317	)	_
8-21	1318-1321	and	_
8-22	1322-1324	in	_
8-23	1325-1331	reward	_
8-24	1332-1346	responsiveness	_
8-25	1347-1348	(	_
8-26	1349-1360	subcortical	_
8-27	1361-1362	,	_
8-28	1363-1371	salience	_
8-29	1372-1373	,	_
8-30	1374-1387	motor/sensory	_
8-31	1388-1389	)	_
8-32	1390-1391	.	_

Text=Connectivity strength did not change with treatment, and strength at post-treatment also predicted abstinence during follow-up (r (df=39) =0.34, p=0.03).
9-1	1392-1404	Connectivity	_
9-2	1405-1413	strength	_
9-3	1414-1417	did	_
9-4	1418-1421	not	_
9-5	1422-1428	change	_
9-6	1429-1433	with	_
9-7	1434-1443	treatment	_
9-8	1444-1445	,	_
9-9	1446-1449	and	_
9-10	1450-1458	strength	_
9-11	1459-1461	at	_
9-12	1462-1476	post-treatment	_
9-13	1477-1481	also	_
9-14	1482-1491	predicted	_
9-15	1492-1502	abstinence	_
9-16	1503-1509	during	_
9-17	1510-1519	follow-up	_
9-18	1520-1521	(	_
9-19	1522-1523	r	_
9-20	1524-1525	(	_
9-21	1526-1531	df=39	_
9-22	1532-1533	)	_
9-23	1534-1539	=0.34	_
9-24	1540-1541	,	_
9-25	1542-1548	p=0.03	_
9-26	1549-1550	)	_
9-27	1551-1552	.	_

Text=Network strength in the independent sample predicted treatment response with 64% accuracy by itself, and with 71% accuracy when combined with baseline cocaine-use.
10-1	1553-1560	Network	_
10-2	1561-1569	strength	_
10-3	1570-1572	in	_
10-4	1573-1576	the	_
10-5	1577-1588	independent	_
10-6	1589-1595	sample	_
10-7	1596-1605	predicted	_
10-8	1606-1615	treatment	_
10-9	1616-1624	response	_
10-10	1625-1629	with	_
10-11	1630-1632	64	_
10-12	1633-1634	%	_
10-13	1635-1643	accuracy	_
10-14	1644-1646	by	_
10-15	1647-1653	itself	_
10-16	1654-1655	,	_
10-17	1656-1659	and	_
10-18	1660-1664	with	_
10-19	1665-1667	71	_
10-20	1668-1669	%	_
10-21	1670-1678	accuracy	_
10-22	1679-1683	when	_
10-23	1684-1692	combined	_
10-24	1693-1697	with	_
10-25	1698-1706	baseline	_
10-26	1707-1718	cocaine-use	_
10-27	1719-1720	.	_

Text=Conclusions: These data demonstrate that individual differences in large-scale neural networks contribute to variability in treatment outcomes for cocaine use disorder.
11-1	1721-1732	Conclusions	_
11-2	1733-1734	:	_
11-3	1735-1740	These	_
11-4	1741-1745	data	_
11-5	1746-1757	demonstrate	_
11-6	1758-1762	that	_
11-7	1763-1773	individual	_
11-8	1774-1785	differences	_
11-9	1786-1788	in	_
11-10	1789-1800	large-scale	_
11-11	1801-1807	neural	_
11-12	1808-1816	networks	_
11-13	1817-1827	contribute	_
11-14	1828-1830	to	_
11-15	1831-1842	variability	_
11-16	1843-1845	in	_
11-17	1846-1855	treatment	_
11-18	1856-1864	outcomes	_
11-19	1865-1868	for	_
11-20	1869-1876	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
11-21	1877-1880	use	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
11-22	1881-1889	disorder	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
11-23	1890-1891	.	_

Text=They identify specific abstinence networks that may be targeted in novel interventions.
12-1	1892-1896	They	_
12-2	1897-1905	identify	_
12-3	1906-1914	specific	_
12-4	1915-1925	abstinence	_
12-5	1926-1934	networks	_
12-6	1935-1939	that	_
12-7	1940-1943	may	_
12-8	1944-1946	be	_
12-9	1947-1955	targeted	_
12-10	1956-1958	in	_
12-11	1959-1964	novel	_
12-12	1965-1978	interventions	_
12-13	1979-1980	.	_

Text=Methods Participants and recruitment Participants (n=74) were recruited from a randomized controlled trial of behavioral therapy plus galantamine or placebo treatment for cocaine-use disorder.
13-1	1981-1988	Methods	_
13-2	1989-2001	Participants	_
13-3	2002-2005	and	_
13-4	2006-2017	recruitment	_
13-5	2018-2030	Participants	_
13-6	2031-2032	(	_
13-7	2033-2037	n=74	_
13-8	2038-2039	)	_
13-9	2040-2044	were	_
13-10	2045-2054	recruited	_
13-11	2055-2059	from	_
13-12	2060-2061	a	_
13-13	2062-2072	randomized	_
13-14	2073-2083	controlled	_
13-15	2084-2089	trial	_
13-16	2090-2092	of	_
13-17	2093-2103	behavioral	_
13-18	2104-2111	therapy	_
13-19	2112-2116	plus	_
13-20	2117-2128	galantamine	_
13-21	2129-2131	or	_
13-22	2132-2139	placebo	_
13-23	2140-2149	treatment	_
13-24	2150-2153	for	_
13-25	2154-2165	cocaine-use	_
13-26	2166-2174	disorder	_
13-27	2175-2176	.	_

Text=Demographic and clinical characteristics are shown in Table 1.
14-1	2177-2188	Demographic	_
14-2	2189-2192	and	_
14-3	2193-2201	clinical	_
14-4	2202-2217	characteristics	_
14-5	2218-2221	are	_
14-6	2222-2227	shown	_
14-7	2228-2230	in	_
14-8	2231-2236	Table	_
14-9	2237-2238	1	_
14-10	2239-2240	.	_

Text=In addition to seeking treatment for cocaine, all participants were currently enrolled in methadone maintenance treatment for opioid-use disorder.
15-1	2241-2243	In	_
15-2	2244-2252	addition	_
15-3	2253-2255	to	_
15-4	2256-2263	seeking	_
15-5	2264-2273	treatment	_
15-6	2274-2277	for	_
15-7	2278-2285	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
15-8	2286-2287	,	_
15-9	2288-2291	all	_
15-10	2292-2304	participants	_
15-11	2305-2309	were	_
15-12	2310-2319	currently	_
15-13	2320-2328	enrolled	_
15-14	2329-2331	in	_
15-15	2332-2341	methadone	_
15-16	2342-2353	maintenance	_
15-17	2354-2363	treatment	_
15-18	2364-2367	for	_
15-19	2368-2378	opioid-use	http://maven.renci.org/NeuroBridge/neurobridge#OpioidAbuse
15-20	2379-2387	disorder	http://maven.renci.org/NeuroBridge/neurobridge#OpioidAbuse
15-21	2388-2389	.	_

Text=Consistent with the parent trial, the fMRI sample was predominantly male (63.5%) and unemployed (73.0%), with multiple prior treatment attempts (outpatient: 2.97± 3.63, inpatient: 3.16±5.24) and legal problems (lifetime arrests: 5.46±6.29).
16-1	2390-2400	Consistent	_
16-2	2401-2405	with	_
16-3	2406-2409	the	_
16-4	2410-2416	parent	_
16-5	2417-2422	trial	_
16-6	2423-2424	,	_
16-7	2425-2428	the	_
16-8	2429-2433	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
16-9	2434-2440	sample	_
16-10	2441-2444	was	_
16-11	2445-2458	predominantly	_
16-12	2459-2463	male	_
16-13	2464-2465	(	_
16-14	2466-2470	63.5	_
16-15	2471-2472	%	_
16-16	2473-2474	)	_
16-17	2475-2478	and	_
16-18	2479-2489	unemployed	_
16-19	2490-2491	(	_
16-20	2492-2496	73.0	_
16-21	2497-2498	%	_
16-22	2499-2500	)	_
16-23	2501-2502	,	_
16-24	2503-2507	with	_
16-25	2508-2516	multiple	_
16-26	2517-2522	prior	_
16-27	2523-2532	treatment	_
16-28	2533-2541	attempts	_
16-29	2542-2543	(	_
16-30	2544-2554	outpatient	_
16-31	2555-2556	:	_
16-32	2557-2562	2.97±	_
16-33	2563-2567	3.63	_
16-34	2568-2569	,	_
16-35	2570-2579	inpatient	_
16-36	2580-2581	:	_
16-37	2582-2591	3.16±5.24	_
16-38	2592-2593	)	_
16-39	2594-2597	and	_
16-40	2598-2603	legal	_
16-41	2604-2612	problems	_
16-42	2613-2614	(	_
16-43	2615-2623	lifetime	_
16-44	2624-2631	arrests	_
16-45	2632-2633	:	_
16-46	2634-2643	5.46±6.29	_
16-47	2644-2645	)	_
16-48	2646-2647	.	_

Text=Following exclusion of individuals with incomplete data (n=4) or excessive motion during scanning (n=17; further details below), the final sample used for CPM analyses consisted of 53 individuals (73.6% male).
17-1	2648-2657	Following	_
17-2	2658-2667	exclusion	_
17-3	2668-2670	of	_
17-4	2671-2682	individuals	_
17-5	2683-2687	with	_
17-6	2688-2698	incomplete	_
17-7	2699-2703	data	_
17-8	2704-2705	(	_
17-9	2706-2709	n=4	_
17-10	2710-2711	)	_
17-11	2712-2714	or	_
17-12	2715-2724	excessive	_
17-13	2725-2731	motion	_
17-14	2732-2738	during	_
17-15	2739-2747	scanning	_
17-16	2748-2749	(	_
17-17	2750-2754	n=17	_
17-18	2755-2756	;	_
17-19	2757-2764	further	_
17-20	2765-2772	details	_
17-21	2773-2778	below	_
17-22	2779-2780	)	_
17-23	2781-2782	,	_
17-24	2783-2786	the	_
17-25	2787-2792	final	_
17-26	2793-2799	sample	_
17-27	2800-2804	used	_
17-28	2805-2808	for	_
17-29	2809-2812	CPM	_
17-30	2813-2821	analyses	_
17-31	2822-2831	consisted	_
17-32	2832-2834	of	_
17-33	2835-2837	53	_
17-34	2838-2849	individuals	_
17-35	2850-2851	(	_
17-36	2852-2856	73.6	_
17-37	2857-2858	%	_
17-38	2859-2863	male	_
17-39	2864-2865	)	_
17-40	2866-2867	.	_

Text=Further details on motion controls and follow-up analyses controlling for time of scanning are provided in the Supplemental Materials.
18-1	2868-2875	Further	_
18-2	2876-2883	details	_
18-3	2884-2886	on	_
18-4	2887-2893	motion	_
18-5	2894-2902	controls	_
18-6	2903-2906	and	_
18-7	2907-2916	follow-up	_
18-8	2917-2925	analyses	_
18-9	2926-2937	controlling	_
18-10	2938-2941	for	_
18-11	2942-2946	time	_
18-12	2947-2949	of	_
18-13	2950-2958	scanning	_
18-14	2959-2962	are	_
18-15	2963-2971	provided	_
18-16	2972-2974	in	_
18-17	2975-2978	the	_
18-18	2979-2991	Supplemental	_
18-19	2992-3001	Materials	_
18-20	3002-3003	.	_

Text=As shown in Table 1, included versus excluded participants did not differ in years of cocaine-use, treatment assignment or other clinical variables with the exception of sex (p=.004).
19-1	3004-3006	As	_
19-2	3007-3012	shown	_
19-3	3013-3015	in	_
19-4	3016-3021	Table	_
19-5	3022-3023	1	_
19-6	3024-3025	,	_
19-7	3026-3034	included	_
19-8	3035-3041	versus	_
19-9	3042-3050	excluded	_
19-10	3051-3063	participants	_
19-11	3064-3067	did	_
19-12	3068-3071	not	_
19-13	3072-3078	differ	_
19-14	3079-3081	in	_
19-15	3082-3087	years	_
19-16	3088-3090	of	_
19-17	3091-3102	cocaine-use	_
19-18	3103-3104	,	_
19-19	3105-3114	treatment	_
19-20	3115-3125	assignment	_
19-21	3126-3128	or	_
19-22	3129-3134	other	_
19-23	3135-3143	clinical	_
19-24	3144-3153	variables	_
19-25	3154-3158	with	_
19-26	3159-3162	the	_
19-27	3163-3172	exception	_
19-28	3173-3175	of	_
19-29	3176-3179	sex	_
19-30	3180-3181	(	_
19-31	3182-3188	p=.004	_
19-32	3189-3190	)	_
19-33	3191-3192	.	_

Text=As in our prior work, abstinence during treatment was determined based on results of biweekly urine testing and defined as the percentage of urines negative for cocaine provided during treatment.
20-1	3193-3195	As	_
20-2	3196-3198	in	_
20-3	3199-3202	our	_
20-4	3203-3208	prior	_
20-5	3209-3213	work	_
20-6	3214-3215	,	_
20-7	3216-3226	abstinence	_
20-8	3227-3233	during	_
20-9	3234-3243	treatment	_
20-10	3244-3247	was	_
20-11	3248-3258	determined	_
20-12	3259-3264	based	_
20-13	3265-3267	on	_
20-14	3268-3275	results	_
20-15	3276-3278	of	_
20-16	3279-3287	biweekly	_
20-17	3288-3293	urine	_
20-18	3294-3301	testing	_
20-19	3302-3305	and	_
20-20	3306-3313	defined	_
20-21	3314-3316	as	_
20-22	3317-3320	the	_
20-23	3321-3331	percentage	_
20-24	3332-3334	of	_
20-25	3335-3341	urines	_
20-26	3342-3350	negative	_
20-27	3351-3354	for	_
20-28	3355-3362	cocaine	_
20-29	3363-3371	provided	_
20-30	3372-3378	during	_
20-31	3379-3388	treatment	_
20-32	3389-3390	.	_

Text=All participants provided written informed consent following a complete description of study procedures.
21-1	3391-3394	All	_
21-2	3395-3407	participants	_
21-3	3408-3416	provided	_
21-4	3417-3424	written	_
21-5	3425-3433	informed	_
21-6	3434-3441	consent	_
21-7	3442-3451	following	_
21-8	3452-3453	a	_
21-9	3454-3462	complete	_
21-10	3463-3474	description	_
21-11	3475-3477	of	_
21-12	3478-3483	study	_
21-13	3484-3494	procedures	_
21-14	3495-3496	.	_

Text=Neuroimaging data acquisition fMRI data were acquired during performance of a well-validated Monetary Incentive Delay task (Supplemental Figure 1; details on acquisition in Supplemental Materials).
22-1	3497-3509	Neuroimaging	_
22-2	3510-3514	data	_
22-3	3515-3526	acquisition	_
22-4	3527-3531	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
22-5	3532-3536	data	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
22-6	3537-3541	were	_
22-7	3542-3550	acquired	_
22-8	3551-3557	during	_
22-9	3558-3569	performance	_
22-10	3570-3572	of	_
22-11	3573-3574	a	_
22-12	3575-3589	well-validated	_
22-13	3590-3598	Monetary	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
22-14	3599-3608	Incentive	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
22-15	3609-3614	Delay	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
22-16	3615-3619	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
22-17	3620-3621	(	_
22-18	3622-3634	Supplemental	_
22-19	3635-3641	Figure	_
22-20	3642-3643	1	_
22-21	3644-3645	;	_
22-22	3646-3653	details	_
22-23	3654-3656	on	_
22-24	3657-3668	acquisition	_
22-25	3669-3671	in	_
22-26	3672-3684	Supplemental	_
22-27	3685-3694	Materials	_
22-28	3695-3696	)	_
22-29	3697-3698	.	_

Text=Preprocessing was conducted using SPM8 and the BioImage Suite and is described in the Supplemental Materials.
23-1	3699-3712	Preprocessing	_
23-2	3713-3716	was	_
23-3	3717-3726	conducted	_
23-4	3727-3732	using	_
23-5	3733-3737	SPM8	_
23-6	3738-3741	and	_
23-7	3742-3745	the	_
23-8	3746-3754	BioImage	_
23-9	3755-3760	Suite	_
23-10	3761-3764	and	_
23-11	3765-3767	is	_
23-12	3768-3777	described	_
23-13	3778-3780	in	_
23-14	3781-3784	the	_
23-15	3785-3797	Supplemental	_
23-16	3798-3807	Materials	_
23-17	3808-3809	.	_

Text=Functional connectivity Whole-brain functional connectivity analyses were conducted using the BioImage suite, using previously described methods.
24-1	3810-3820	Functional	_
24-2	3821-3833	connectivity	_
24-3	3834-3845	Whole-brain	_
24-4	3846-3856	functional	_
24-5	3857-3869	connectivity	_
24-6	3870-3878	analyses	_
24-7	3879-3883	were	_
24-8	3884-3893	conducted	_
24-9	3894-3899	using	_
24-10	3900-3903	the	_
24-11	3904-3912	BioImage	_
24-12	3913-3918	suite	_
24-13	3919-3920	,	_
24-14	3921-3926	using	_
24-15	3927-3937	previously	_
24-16	3938-3947	described	_
24-17	3948-3955	methods	_
24-18	3956-3957	.	_

Text=Network nodes were defined using the Shen 268-node brain atlas which includes the cortex, subcortex and cerebellum, as in other prior CPM work (further details in Supplemental Materials).
25-1	3958-3965	Network	_
25-2	3966-3971	nodes	_
25-3	3972-3976	were	_
25-4	3977-3984	defined	_
25-5	3985-3990	using	_
25-6	3991-3994	the	_
25-7	3995-3999	Shen	_
25-8	4000-4008	268-node	_
25-9	4009-4014	brain	_
25-10	4015-4020	atlas	_
25-11	4021-4026	which	_
25-12	4027-4035	includes	_
25-13	4036-4039	the	_
25-14	4040-4046	cortex	_
25-15	4047-4048	,	_
25-16	4049-4058	subcortex	_
25-17	4059-4062	and	_
25-18	4063-4073	cerebellum	_
25-19	4074-4075	,	_
25-20	4076-4078	as	_
25-21	4079-4081	in	_
25-22	4082-4087	other	_
25-23	4088-4093	prior	_
25-24	4094-4097	CPM	_
25-25	4098-4102	work	_
25-26	4103-4104	(	_
25-27	4105-4112	further	_
25-28	4113-4120	details	_
25-29	4121-4123	in	_
25-30	4124-4136	Supplemental	_
25-31	4137-4146	Materials	_
25-32	4147-4148	)	_
25-33	4149-4150	.	_

Text=Task connectivity was calculated based on the ‘ raw ’ task timecourses, with no regression of task-evoked activity.
26-1	4151-4155	Task	_
26-2	4156-4168	connectivity	_
26-3	4169-4172	was	_
26-4	4173-4183	calculated	_
26-5	4184-4189	based	_
26-6	4190-4192	on	_
26-7	4193-4196	the	_
26-8	4197-4198	‘	_
26-9	4199-4202	raw	_
26-10	4203-4204	’	_
26-11	4205-4209	task	_
26-12	4210-4221	timecourses	_
26-13	4222-4223	,	_
26-14	4224-4228	with	_
26-15	4229-4231	no	_
26-16	4232-4242	regression	_
26-17	4243-4245	of	_
26-18	4246-4257	task-evoked	_
26-19	4258-4266	activity	_
26-20	4267-4268	.	_

Text=This involved computation of mean time courses for each of the 268 nodes (i.e., average time course of voxels within the node) for use in node-by-node pairwise Pearson ’ s correlations.
27-1	4269-4273	This	_
27-2	4274-4282	involved	_
27-3	4283-4294	computation	_
27-4	4295-4297	of	_
27-5	4298-4302	mean	_
27-6	4303-4307	time	_
27-7	4308-4315	courses	_
27-8	4316-4319	for	_
27-9	4320-4324	each	_
27-10	4325-4327	of	_
27-11	4328-4331	the	_
27-12	4332-4335	268	_
27-13	4336-4341	nodes	_
27-14	4342-4343	(	_
27-15	4344-4348	i.e.	_
27-16	4349-4350	,	_
27-17	4351-4358	average	_
27-18	4359-4363	time	_
27-19	4364-4370	course	_
27-20	4371-4373	of	_
27-21	4374-4380	voxels	_
27-22	4381-4387	within	_
27-23	4388-4391	the	_
27-24	4392-4396	node	_
27-25	4397-4398	)	_
27-26	4399-4402	for	_
27-27	4403-4406	use	_
27-28	4407-4409	in	_
27-29	4410-4422	node-by-node	_
27-30	4423-4431	pairwise	_
27-31	4432-4439	Pearson	_
27-32	4440-4441	’	_
27-33	4442-4443	s	_
27-34	4444-4456	correlations	_
27-35	4457-4458	.	_

Text=Resultant r-values were transformed using Fisher ’ s z-transformation to create symmetric 268x268 connectivity matrices in which each element of the matrix represents the strength of connection between two individual nodes (hereafter referred to as an edge).
28-1	4459-4468	Resultant	_
28-2	4469-4477	r-values	_
28-3	4478-4482	were	_
28-4	4483-4494	transformed	_
28-5	4495-4500	using	_
28-6	4501-4507	Fisher	_
28-7	4508-4509	’	_
28-8	4510-4511	s	_
28-9	4512-4528	z-transformation	_
28-10	4529-4531	to	_
28-11	4532-4538	create	_
28-12	4539-4548	symmetric	_
28-13	4549-4556	268x268	_
28-14	4557-4569	connectivity	_
28-15	4570-4578	matrices	_
28-16	4579-4581	in	_
28-17	4582-4587	which	_
28-18	4588-4592	each	_
28-19	4593-4600	element	_
28-20	4601-4603	of	_
28-21	4604-4607	the	_
28-22	4608-4614	matrix	_
28-23	4615-4625	represents	_
28-24	4626-4629	the	_
28-25	4630-4638	strength	_
28-26	4639-4641	of	_
28-27	4642-4652	connection	_
28-28	4653-4660	between	_
28-29	4661-4664	two	_
28-30	4665-4675	individual	_
28-31	4676-4681	nodes	_
28-32	4682-4683	(	_
28-33	4684-4693	hereafter	_
28-34	4694-4702	referred	_
28-35	4703-4705	to	_
28-36	4706-4708	as	_
28-37	4709-4711	an	_
28-38	4712-4716	edge	_
28-39	4717-4718	)	_
28-40	4719-4720	.	_

Text=Connectome-based predictive modeling (CPM) CPM was conducted using previously validated custom MATLAB scripts.
29-1	4721-4737	Connectome-based	_
29-2	4738-4748	predictive	_
29-3	4749-4757	modeling	_
29-4	4758-4759	(	_
29-5	4760-4763	CPM	_
29-6	4764-4765	)	_
29-7	4766-4769	CPM	_
29-8	4770-4773	was	_
29-9	4774-4783	conducted	_
29-10	4784-4789	using	_
29-11	4790-4800	previously	_
29-12	4801-4810	validated	_
29-13	4811-4817	custom	_
29-14	4818-4824	MATLAB	_
29-15	4825-4832	scripts	_
29-16	4833-4834	.	_

Text=A schematic diagram of CPM is shown in Supplemental Figure 2.
30-1	4835-4836	A	_
30-2	4837-4846	schematic	_
30-3	4847-4854	diagram	_
30-4	4855-4857	of	_
30-5	4858-4861	CPM	_
30-6	4862-4864	is	_
30-7	4865-4870	shown	_
30-8	4871-4873	in	_
30-9	4874-4886	Supplemental	_
30-10	4887-4893	Figure	_
30-11	4894-4895	2	_
30-12	4896-4897	.	_

Text=Briefly, CPM takes group connectivity matrices and behavioral data (in this case, percentage of cocaine-negative urines during treatment) as input to generate a predictive model of the behavioral data from connectivity matrices.
31-1	4898-4905	Briefly	_
31-2	4906-4907	,	_
31-3	4908-4911	CPM	_
31-4	4912-4917	takes	_
31-5	4918-4923	group	_
31-6	4924-4936	connectivity	_
31-7	4937-4945	matrices	_
31-8	4946-4949	and	_
31-9	4950-4960	behavioral	_
31-10	4961-4965	data	_
31-11	4966-4967	(	_
31-12	4968-4970	in	_
31-13	4971-4975	this	_
31-14	4976-4980	case	_
31-15	4981-4982	,	_
31-16	4983-4993	percentage	_
31-17	4994-4996	of	_
31-18	4997-5013	cocaine-negative	_
31-19	5014-5020	urines	_
31-20	5021-5027	during	_
31-21	5028-5037	treatment	_
31-22	5038-5039	)	_
31-23	5040-5042	as	_
31-24	5043-5048	input	_
31-25	5049-5051	to	_
31-26	5052-5060	generate	_
31-27	5061-5062	a	_
31-28	5063-5073	predictive	_
31-29	5074-5079	model	_
31-30	5080-5082	of	_
31-31	5083-5086	the	_
31-32	5087-5097	behavioral	_
31-33	5098-5102	data	_
31-34	5103-5107	from	_
31-35	5108-5120	connectivity	_
31-36	5121-5129	matrices	_
31-37	5130-5131	.	_

Text=Edges and behavioral data from the training dataset are correlated using regression analyses (here using either Pearson ’ s correlation or partial correlation) to identify positive and negative predictive networks.
32-1	5132-5137	Edges	_
32-2	5138-5141	and	_
32-3	5142-5152	behavioral	_
32-4	5153-5157	data	_
32-5	5158-5162	from	_
32-6	5163-5166	the	_
32-7	5167-5175	training	_
32-8	5176-5183	dataset	_
32-9	5184-5187	are	_
32-10	5188-5198	correlated	_
32-11	5199-5204	using	_
32-12	5205-5215	regression	_
32-13	5216-5224	analyses	_
32-14	5225-5226	(	_
32-15	5227-5231	here	_
32-16	5232-5237	using	_
32-17	5238-5244	either	_
32-18	5245-5252	Pearson	_
32-19	5253-5254	’	_
32-20	5255-5256	s	_
32-21	5257-5268	correlation	_
32-22	5269-5271	or	_
32-23	5272-5279	partial	_
32-24	5280-5291	correlation	_
32-25	5292-5293	)	_
32-26	5294-5296	to	_
32-27	5297-5305	identify	_
32-28	5306-5314	positive	_
32-29	5315-5318	and	_
32-30	5319-5327	negative	_
32-31	5328-5338	predictive	_
32-32	5339-5347	networks	_
32-33	5348-5349	.	_

Text=Positive networks are networks for which increased edge weights (increased connectivity) are associated with the variable of interest, whereas negative networks are networks for which decreased edge weights (decreased connectivity) are associated with the variable of interest.
33-1	5350-5358	Positive	_
33-2	5359-5367	networks	_
33-3	5368-5371	are	_
33-4	5372-5380	networks	_
33-5	5381-5384	for	_
33-6	5385-5390	which	_
33-7	5391-5400	increased	_
33-8	5401-5405	edge	_
33-9	5406-5413	weights	_
33-10	5414-5415	(	_
33-11	5416-5425	increased	_
33-12	5426-5438	connectivity	_
33-13	5439-5440	)	_
33-14	5441-5444	are	_
33-15	5445-5455	associated	_
33-16	5456-5460	with	_
33-17	5461-5464	the	_
33-18	5465-5473	variable	_
33-19	5474-5476	of	_
33-20	5477-5485	interest	_
33-21	5486-5487	,	_
33-22	5488-5495	whereas	_
33-23	5496-5504	negative	_
33-24	5505-5513	networks	_
33-25	5514-5517	are	_
33-26	5518-5526	networks	_
33-27	5527-5530	for	_
33-28	5531-5536	which	_
33-29	5537-5546	decreased	_
33-30	5547-5551	edge	_
33-31	5552-5559	weights	_
33-32	5560-5561	(	_
33-33	5562-5571	decreased	_
33-34	5572-5584	connectivity	_
33-35	5585-5586	)	_
33-36	5587-5590	are	_
33-37	5591-5601	associated	_
33-38	5602-5606	with	_
33-39	5607-5610	the	_
33-40	5611-5619	variable	_
33-41	5620-5622	of	_
33-42	5623-5631	interest	_
33-43	5632-5633	.	_

Text=While both networks are used for predicting the same variable, they are by definition independent - as a single edge cannot be both a positive and negative predictor.
34-1	5634-5639	While	_
34-2	5640-5644	both	_
34-3	5645-5653	networks	_
34-4	5654-5657	are	_
34-5	5658-5662	used	_
34-6	5663-5666	for	_
34-7	5667-5677	predicting	_
34-8	5678-5681	the	_
34-9	5682-5686	same	_
34-10	5687-5695	variable	_
34-11	5696-5697	,	_
34-12	5698-5702	they	_
34-13	5703-5706	are	_
34-14	5707-5709	by	_
34-15	5710-5720	definition	_
34-16	5721-5732	independent	_
34-17	5733-5734	-	_
34-18	5735-5737	as	_
34-19	5738-5739	a	_
34-20	5740-5746	single	_
34-21	5747-5751	edge	_
34-22	5752-5755	can	_
34-23	5756-5759	not	_
34-24	5760-5762	be	_
34-25	5763-5767	both	_
34-26	5768-5769	a	_
34-27	5770-5778	positive	_
34-28	5779-5782	and	_
34-29	5783-5791	negative	_
34-30	5792-5801	predictor	_
34-31	5802-5803	.	_

Text=Single subject summary statistics are then created as the sum of the significant edge weights in each network and entered into predictive models assuming linear relationships with behavioral data.
35-1	5804-5810	Single	_
35-2	5811-5818	subject	_
35-3	5819-5826	summary	_
35-4	5827-5837	statistics	_
35-5	5838-5841	are	_
35-6	5842-5846	then	_
35-7	5847-5854	created	_
35-8	5855-5857	as	_
35-9	5858-5861	the	_
35-10	5862-5865	sum	_
35-11	5866-5868	of	_
35-12	5869-5872	the	_
35-13	5873-5884	significant	_
35-14	5885-5889	edge	_
35-15	5890-5897	weights	_
35-16	5898-5900	in	_
35-17	5901-5905	each	_
35-18	5906-5913	network	_
35-19	5914-5917	and	_
35-20	5918-5925	entered	_
35-21	5926-5930	into	_
35-22	5931-5941	predictive	_
35-23	5942-5948	models	_
35-24	5949-5957	assuming	_
35-25	5958-5964	linear	_
35-26	5965-5978	relationships	_
35-27	5979-5983	with	_
35-28	5984-5994	behavioral	_
35-29	5995-5999	data	_
35-30	6000-6001	.	_

Text=Resultant polynomial coefficients (linear equation including slope and intercept) are then applied to the test dataset to predict behaviors.
36-1	6002-6011	Resultant	_
36-2	6012-6022	polynomial	_
36-3	6023-6035	coefficients	_
36-4	6036-6037	(	_
36-5	6038-6044	linear	_
36-6	6045-6053	equation	_
36-7	6054-6063	including	_
36-8	6064-6069	slope	_
36-9	6070-6073	and	_
36-10	6074-6083	intercept	_
36-11	6084-6085	)	_
36-12	6086-6089	are	_
36-13	6090-6094	then	_
36-14	6095-6102	applied	_
36-15	6103-6105	to	_
36-16	6106-6109	the	_
36-17	6110-6114	test	_
36-18	6115-6122	dataset	_
36-19	6123-6125	to	_
36-20	6126-6133	predict	_
36-21	6134-6143	behaviors	_
36-22	6144-6145	.	_

Text=In the case of leave-one-out cross-validation (used here), a single participant ’ s predicted value (i.e., the ‘ left-out ’ participant) is generated by taking the data from all other participants as the training dataset in an iterative manner until all participants have a predicted value.
37-1	6146-6148	In	_
37-2	6149-6152	the	_
37-3	6153-6157	case	_
37-4	6158-6160	of	_
37-5	6161-6174	leave-one-out	_
37-6	6175-6191	cross-validation	_
37-7	6192-6193	(	_
37-8	6194-6198	used	_
37-9	6199-6203	here	_
37-10	6204-6205	)	_
37-11	6206-6207	,	_
37-12	6208-6209	a	_
37-13	6210-6216	single	_
37-14	6217-6228	participant	_
37-15	6229-6230	’	_
37-16	6231-6232	s	_
37-17	6233-6242	predicted	_
37-18	6243-6248	value	_
37-19	6249-6250	(	_
37-20	6251-6255	i.e.	_
37-21	6256-6257	,	_
37-22	6258-6261	the	_
37-23	6262-6263	‘	_
37-24	6264-6272	left-out	_
37-25	6273-6274	’	_
37-26	6275-6286	participant	_
37-27	6287-6288	)	_
37-28	6289-6291	is	_
37-29	6292-6301	generated	_
37-30	6302-6304	by	_
37-31	6305-6311	taking	_
37-32	6312-6315	the	_
37-33	6316-6320	data	_
37-34	6321-6325	from	_
37-35	6326-6329	all	_
37-36	6330-6335	other	_
37-37	6336-6348	participants	_
37-38	6349-6351	as	_
37-39	6352-6355	the	_
37-40	6356-6364	training	_
37-41	6365-6372	dataset	_
37-42	6373-6375	in	_
37-43	6376-6378	an	_
37-44	6379-6388	iterative	_
37-45	6389-6395	manner	_
37-46	6396-6401	until	_
37-47	6402-6405	all	_
37-48	6406-6418	participants	_
37-49	6419-6423	have	_
37-50	6424-6425	a	_
37-51	6426-6435	predicted	_
37-52	6436-6441	value	_
37-53	6442-6443	.	_

Text=Model performance (i.e., correspondence between predicted and actual values) was assessed using Spearman ’ s rho correlations.
38-1	6444-6449	Model	_
38-2	6450-6461	performance	_
38-3	6462-6463	(	_
38-4	6464-6468	i.e.	_
38-5	6469-6470	,	_
38-6	6471-6485	correspondence	_
38-7	6486-6493	between	_
38-8	6494-6503	predicted	_
38-9	6504-6507	and	_
38-10	6508-6514	actual	_
38-11	6515-6521	values	_
38-12	6522-6523	)	_
38-13	6524-6527	was	_
38-14	6528-6536	assessed	_
38-15	6537-6542	using	_
38-16	6543-6551	Spearman	_
38-17	6552-6553	’	_
38-18	6554-6555	s	_
38-19	6556-6559	rho	_
38-20	6560-6572	correlations	_
38-21	6573-6574	.	_

Text=When using leave-one-out cross-validation, analyses in the leave-one-out folds are not wholly independent and the number of degrees of freedom is thus overestimated for parametric p-values based on correlation.
39-1	6575-6579	When	_
39-2	6580-6585	using	_
39-3	6586-6599	leave-one-out	_
39-4	6600-6616	cross-validation	_
39-5	6617-6618	,	_
39-6	6619-6627	analyses	_
39-7	6628-6630	in	_
39-8	6631-6634	the	_
39-9	6635-6648	leave-one-out	_
39-10	6649-6654	folds	_
39-11	6655-6658	are	_
39-12	6659-6662	not	_
39-13	6663-6669	wholly	_
39-14	6670-6681	independent	_
39-15	6682-6685	and	_
39-16	6686-6689	the	_
39-17	6690-6696	number	_
39-18	6697-6699	of	_
39-19	6700-6707	degrees	_
39-20	6708-6710	of	_
39-21	6711-6718	freedom	_
39-22	6719-6721	is	_
39-23	6722-6726	thus	_
39-24	6727-6740	overestimated	_
39-25	6741-6744	for	_
39-26	6745-6755	parametric	_
39-27	6756-6764	p-values	_
39-28	6765-6770	based	_
39-29	6771-6773	on	_
39-30	6774-6785	correlation	_
39-31	6786-6787	.	_

Text=Instead of parametric testing, we therefore performed permutation testing.
40-1	6788-6795	Instead	_
40-2	6796-6798	of	_
40-3	6799-6809	parametric	_
40-4	6810-6817	testing	_
40-5	6818-6819	,	_
40-6	6820-6822	we	_
40-7	6823-6832	therefore	_
40-8	6833-6842	performed	_
40-9	6843-6854	permutation	_
40-10	6855-6862	testing	_
40-11	6863-6864	.	_

Text=To generate null distributions for significance testing, we randomly shuffled the correspondence between behavior variables and connectivity matrices 5,000 times and re-ran the CPM analysis with the shuffled data.
41-1	6865-6867	To	_
41-2	6868-6876	generate	_
41-3	6877-6881	null	_
41-4	6882-6895	distributions	_
41-5	6896-6899	for	_
41-6	6900-6912	significance	_
41-7	6913-6920	testing	_
41-8	6921-6922	,	_
41-9	6923-6925	we	_
41-10	6926-6934	randomly	_
41-11	6935-6943	shuffled	_
41-12	6944-6947	the	_
41-13	6948-6962	correspondence	_
41-14	6963-6970	between	_
41-15	6971-6979	behavior	_
41-16	6980-6989	variables	_
41-17	6990-6993	and	_
41-18	6994-7006	connectivity	_
41-19	7007-7015	matrices	_
41-20	7016-7021	5,000	_
41-21	7022-7027	times	_
41-22	7028-7031	and	_
41-23	7032-7038	re-ran	_
41-24	7039-7042	the	_
41-25	7043-7046	CPM	_
41-26	7047-7055	analysis	_
41-27	7056-7060	with	_
41-28	7061-7064	the	_
41-29	7065-7073	shuffled	_
41-30	7074-7078	data	_
41-31	7079-7080	.	_

Text=Based on these null distributions, the p-values for leave-one-out predictions were calculated as in prior work.
42-1	7081-7086	Based	_
42-2	7087-7089	on	_
42-3	7090-7095	these	_
42-4	7096-7100	null	_
42-5	7101-7114	distributions	_
42-6	7115-7116	,	_
42-7	7117-7120	the	_
42-8	7121-7129	p-values	_
42-9	7130-7133	for	_
42-10	7134-7147	leave-one-out	_
42-11	7148-7159	predictions	_
42-12	7160-7164	were	_
42-13	7165-7175	calculated	_
42-14	7176-7178	as	_
42-15	7179-7181	in	_
42-16	7182-7187	prior	_
42-17	7188-7192	work	_
42-18	7193-7194	.	_

Text=Details on characterization of resultant network anatomy are provided in the Supplemental Materials.
43-1	7195-7202	Details	_
43-2	7203-7205	on	_
43-3	7206-7222	characterization	_
43-4	7223-7225	of	_
43-5	7226-7235	resultant	_
43-6	7236-7243	network	_
43-7	7244-7251	anatomy	_
43-8	7252-7255	are	_
43-9	7256-7264	provided	_
43-10	7265-7267	in	_
43-11	7268-7271	the	_
43-12	7272-7284	Supplemental	_
43-13	7285-7294	Materials	_
43-14	7295-7296	.	_

